Effect of low-flow oxygen therapy on 6 minute walk test in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a randomized non-inferiority crossover trial

Patients with pulmonary arterial and distal chronic thromboembolic pulmonary hypertension (PAH/CTEPH) frequently experience exertional dyspnoea with desaturation. Although ambulatory low-flow supplemental oxygen therapy (SOT) is commonly prescribed, its effect via portable concentrators in daily life has not been studied. We investigated the effect of ambulatory SOT on six-minute walk distance (6MWD).

This was a randomized non-inferiority crossover study in patients with PAH or CTEPH desaturating by >3% during exercise. Patients performed two 6MWD tests in randomized order: one in ambient air and one with pulsed low-flow (1–2 L/min) nasal supplemental oxygen (SOT) by a portable back-packed concentrator. The primary outcome was 6MWD with a predefined non-inferiority margin of −35 m for ambient air vs. SOT. Forty patients (age 62 ± 15 years, 21 female, 20 PAH, 20 CTEPH) were included. The mean difference in 6MWD between ambient air and SOT was 0 m (95% CI: −15 to 14 m, P <0.001).Five patients exceeded the minimal clinically important difference of 35 m with SOT. At end-exercise, the cohort desaturated 2% less with SOT (95% CI −3 to −0.2%, P = 0.025) and reported 1 point less dyspnoea (95% CI 0.3 to 1, P < 0.002). These effects were also observed in PAH but not in CTEPH.

Walking on ambient air was non-inferior to low-flow SOT during 6MWD in treated PAH/CTEPH patients with exercise-induced desaturation and relatively preserved exercise capacity. SOT reduced dyspnoea in PAH. Future research should identify SOT responders and develop lighter, more effective devices tailored to patient needs.

ClinicalTrials.gov (NCT06384534)